Broken String Biosciences
Generated by Meeveem AI
"Advancing gene editing safety through high resolution DNA break mapping for cell and gene therapies"
Cambridge
•11 - 50 Employees
•Contract Research
About Broken String Biosciences
Broken String Biosciences develops INDUCE-seq, a Next Generation Sequencing based platform that maps and characterises DNA breaks with unprecedented precision. The technology enables gene therapy developers to assess on-target and off-target edits at high resolution, accelerating the path from discovery to safe, effective treatments for patients who need them. By revealing how genome editors interact with and alter genomes, INDUCE-seq supports the development of safer CRISPR-based therapeutics and novel genome editing systems. The platform is now available to cell and gene therapy developers worldwide, helping to turn transformative treatments into safe clinical realities.
37
Team Members
2020
Founded
Contract Research
Sector
Hybrid
Work Environment
Our Vision
A future where cell and gene therapies revolutionise healthcare and transform lives with unprecedented precision and safety for all patients.
Our Mission
At Broken String Biosciences, our mission is to advance the next generation of more precise, safe, and effective cell and gene therapies through cutting-edge DNA break mapping technology.